Dignify Therapeutics

Raleigh, United States

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

Sep 2024

Grant

Biotechnology Health Care Pharmaceutical Therapeutics

Top Investors

RA Capital ManagementNational Institutes of HealthNational Institute on AgingNorth Carolina Biotechnology CenterEshelman Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dignify Therapeutics

Who are Dignify Therapeutics's investors?

Dignify Therapeutics's investors include RA Capital Management, National Institutes of Health, National Institute on Aging, North Carolina Biotechnology Center, Eshelman Ventures.

Where is Dignify Therapeutics headquartered?

Dignify Therapeutics is headquartered in Raleigh, United States.

What does Dignify Therapeutics do?

Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal.

What stage is Dignify Therapeutics at?

Dignify Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 19, 2024.

MLA

"Dignify Therapeutics — Funding & Investors." VCBacked, September 19, 2024, https://www.vcbacked.co/company/dignify-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Dignify Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/dignify-therapeutics

Wikipedia (cite web)

{{cite web |title=Dignify Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/dignify-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 19, 2024.